In Brief: Avecor Cardiovascular
This article was originally published in The Gray Sheet
Executive Summary
Avecor Cardiovascular: Files 510(k) with FDA for the MYOtherm XP second-generation cardioplegia delivery system. The new system is designed for increased "customer convenience" and "improved manufacturing efficiencies," the firm explains...